Annual conference to update all attendees on state-of-the-art management of lung cancer and other thoracic malignancies; to develop new national research studies in lung cancer and mesothelioma.
TOPICS COVERED
The 3 day programme seeks to increase understanding of multi-disciplines on the nature of clinical practice and research and to learn from clinical experts about implication on UK practice now and in the future.
WHO SHOULD ATTEND?
Multi-disciplinary team involved in thoracic oncology.
